18 May 2022 12:06
MGC Pharmaceuticals Ltd.
PDMR Notification
18 May 2022
ASX, LSE: MXC
MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') wishes to advise that the following Person Discharging Managerial Responsibilities (PDMR) has dealt with shares in MGC Pharma, and this notification is made in accordance the UK Market Abuse Regulations.
The shares the subject of this notice were issued to the PDMR in accordance with a Share Purchase Agreement executed by MGC Pharma and the owners of MediCaNL Inc in April 2021, with the issued shares being the final tranche of deferred consideration payable by MGC Pharma to the PDMR who was a shareholder of MediCaNL Inc.
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||||
(a) | Name | Nadya Lisovoder | |||
2 | Reason for the notification
| ||||
(a) | Position
| Chief Medical Officer | |||
(b) | Initial notification/amendment
| Initial | |||
(c) | If amendment: reason
| n/a | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
Full name of entity | MGC Pharmaceuticals Limited
| ||||
Legal Entity Identifier Code | 213800HRE3FQJ6RK4H10
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| ||||
(a) | Description of the financial instrument, type of instrument | Fully Paid Ordinary Shares | |||
(b) | Identification Code (ISIN)
| AU000000MXC6 | |||
(c) | Nature of transaction | Shares issued as consideration for a corporate entity acquired by the Issuer. | |||
(d) | Currency | Price | Volume | Total | |
AUD | $0.067 | 6,721,179 | 450,319 | ||
Aggregated information | |||||
AUD | $0.067 | 6,721,179 | 450,319 | ||
(e) | Date of transaction
| 2022-05-13 | |||
(f) | Place of transaction
| Outside a trading venue | |||
--Ends--
Authorised for release by the Executive Chair, for further information please contact:
MGC Pharmaceuticals Ltd Roby Zomer CEO & Managing Director +61 8 6382 3390 info@mgcpharma.com.au | MGC Pharmaceuticals Ltd David Lim Company Secretary +61 8 6382 3390 info@mgcpharma.com.au |
UK Broker - Turner Pope Andy Thacker +44 203 657 0050 info@turnerpope.com | UK PR Advisors - Tavistock Charles Vivian / Tim Pearson +44 207 920 3150 mgcpharma@tavistock.co.uk
|
MXC.L (MXC)